Cargando…
Impact of conditioning regimen on peripheral blood hematopoietic cell transplant
AIM: To investigate infused hematopoietic cell doses and their interaction with conditioning regimen intensity +/- total body irradiation (TBI) on outcomes after peripheral blood hematopoietic cell transplant (PBHCT). METHODS: Our retrospective cohort included 247 patients receiving a first, T-reple...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390118/ https://www.ncbi.nlm.nih.gov/pubmed/30815375 http://dx.doi.org/10.5306/wjco.v10.i2.86 |
_version_ | 1783398077372039168 |
---|---|
author | Burns, Michael Singh, Anurag K Hoefer, Carrie C Zhang, Yali Wallace, Paul K Chen, George L Platek, Alexis Winslow, Timothy B Iovoli, Austin J Choi, Christopher Ross, Maureen McCarthy, Philip L Hahn, Theresa |
author_facet | Burns, Michael Singh, Anurag K Hoefer, Carrie C Zhang, Yali Wallace, Paul K Chen, George L Platek, Alexis Winslow, Timothy B Iovoli, Austin J Choi, Christopher Ross, Maureen McCarthy, Philip L Hahn, Theresa |
author_sort | Burns, Michael |
collection | PubMed |
description | AIM: To investigate infused hematopoietic cell doses and their interaction with conditioning regimen intensity +/- total body irradiation (TBI) on outcomes after peripheral blood hematopoietic cell transplant (PBHCT). METHODS: Our retrospective cohort included 247 patients receiving a first, T-replete, human leukocyte antigen-matched allogeneic PBHCT and treated between 2001 and 2012. Correlations were calculated using the Pearson product-moment correlation coefficient. Overall survival and progression free survival curves were generated using the Kaplan-Meier method and compared using the log-rank test. RESULTS: Neutrophil engraftment was significantly faster after reduced intensity TBI based conditioning [reduced intensity conditioning (RIC) + TBI] and > 4 × 10(6) CD34+ cells/kg infused. A higher total nucleated cell dose led to a higher incidence of grade II-IV acute graft-versus-host disease in the myeloablative + TBI regimen group (P = 0.03), but no significant difference in grade III-IV graft-versus-host disease. A higher total nucleated cell dose was also associated with increased incidence of moderate/severe chronic graft-versus-host disease, regardless of conditioning regimen. Overall and progression-free survival were significantly better in patients with a RIC + TBI regimen and total nucleated cell dose > 8 × 10(8)/kg (3 years, overall survival: 70% vs 38%, P = 0.02, 3 years, progression free survival: 64% vs 38%, P = 0.02). CONCLUSION: TBI and conditioning intensity may alter the relationship between infused cell doses and outcomes after PBHCT. Immune cell subsets may predict improved survival after unmanipulated PBHCT. |
format | Online Article Text |
id | pubmed-6390118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-63901182019-02-27 Impact of conditioning regimen on peripheral blood hematopoietic cell transplant Burns, Michael Singh, Anurag K Hoefer, Carrie C Zhang, Yali Wallace, Paul K Chen, George L Platek, Alexis Winslow, Timothy B Iovoli, Austin J Choi, Christopher Ross, Maureen McCarthy, Philip L Hahn, Theresa World J Clin Oncol Retrospective Study AIM: To investigate infused hematopoietic cell doses and their interaction with conditioning regimen intensity +/- total body irradiation (TBI) on outcomes after peripheral blood hematopoietic cell transplant (PBHCT). METHODS: Our retrospective cohort included 247 patients receiving a first, T-replete, human leukocyte antigen-matched allogeneic PBHCT and treated between 2001 and 2012. Correlations were calculated using the Pearson product-moment correlation coefficient. Overall survival and progression free survival curves were generated using the Kaplan-Meier method and compared using the log-rank test. RESULTS: Neutrophil engraftment was significantly faster after reduced intensity TBI based conditioning [reduced intensity conditioning (RIC) + TBI] and > 4 × 10(6) CD34+ cells/kg infused. A higher total nucleated cell dose led to a higher incidence of grade II-IV acute graft-versus-host disease in the myeloablative + TBI regimen group (P = 0.03), but no significant difference in grade III-IV graft-versus-host disease. A higher total nucleated cell dose was also associated with increased incidence of moderate/severe chronic graft-versus-host disease, regardless of conditioning regimen. Overall and progression-free survival were significantly better in patients with a RIC + TBI regimen and total nucleated cell dose > 8 × 10(8)/kg (3 years, overall survival: 70% vs 38%, P = 0.02, 3 years, progression free survival: 64% vs 38%, P = 0.02). CONCLUSION: TBI and conditioning intensity may alter the relationship between infused cell doses and outcomes after PBHCT. Immune cell subsets may predict improved survival after unmanipulated PBHCT. Baishideng Publishing Group Inc 2019-02-24 2019-02-24 /pmc/articles/PMC6390118/ /pubmed/30815375 http://dx.doi.org/10.5306/wjco.v10.i2.86 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Burns, Michael Singh, Anurag K Hoefer, Carrie C Zhang, Yali Wallace, Paul K Chen, George L Platek, Alexis Winslow, Timothy B Iovoli, Austin J Choi, Christopher Ross, Maureen McCarthy, Philip L Hahn, Theresa Impact of conditioning regimen on peripheral blood hematopoietic cell transplant |
title | Impact of conditioning regimen on peripheral blood hematopoietic cell transplant |
title_full | Impact of conditioning regimen on peripheral blood hematopoietic cell transplant |
title_fullStr | Impact of conditioning regimen on peripheral blood hematopoietic cell transplant |
title_full_unstemmed | Impact of conditioning regimen on peripheral blood hematopoietic cell transplant |
title_short | Impact of conditioning regimen on peripheral blood hematopoietic cell transplant |
title_sort | impact of conditioning regimen on peripheral blood hematopoietic cell transplant |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390118/ https://www.ncbi.nlm.nih.gov/pubmed/30815375 http://dx.doi.org/10.5306/wjco.v10.i2.86 |
work_keys_str_mv | AT burnsmichael impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT singhanuragk impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT hoefercarriec impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT zhangyali impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT wallacepaulk impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT chengeorgel impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT platekalexis impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT winslowtimothyb impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT iovoliaustinj impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT choichristopher impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT rossmaureen impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT mccarthyphilipl impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant AT hahntheresa impactofconditioningregimenonperipheralbloodhematopoieticcelltransplant |